TriScreen (NIPT) safely and non-invasively screens for the most common chromosomal aneuploidies (abnormalities) from as early as 10 weeks gestation.

TriScreen NIPT uses a single maternal blood draw from the mother’s arm. It is more accurate than maternal blood tests and ultrasound in the detection of chromosomal aneuploidies, providing a greater sense of comfort.

What is a chromosomal abnormality?

Humans have 23 pairs of chromosomes (46 in total) within almost every cell in our body. One chromosome of each pair comes from our mother, and the other from our father. The first chromosome pairs are labelled 1-22. The last pair of these chromosomes are the sex chromosomes, which determine gender. Females usually have two X chromosomes, and males have an X and a Y chromosome.

A change in the number of chromosomes can lead to a change in development. Having an extra copy of a chromosome is called a trisomy (three copies), while missing a copy of a chromosome (having only one copy) is called a monosomy. A trisomy or monosomy can result in a genetic condition, such as Down syndrome. Individuals with Down syndrome have 3 copies of chromosome 21 (Trisomy 21).

CfDNA Tube

Next Biosciences is proud to be a valued member of The Global NIPT consortium alongside other Illumina-powered laboratories.